Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Peritoneal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Not applicableEnded earlyNCT03412630
What this trial is testing

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
ECOG-ACRIN Cancer Research Group 1
Testing effectiveness (Phase 2)Looking for participantsNCT06946901
What this trial is testing

The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial

Who this might be right for
Hyperthermic Intraperitoneal ChemotherapyPeritoneal Metastatic Pancreatic Cancer
Shanghai Zhongshan Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00182767
What this trial is testing

Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer

Who this might be right for
Fallopian Tube CancerFemale Reproductive CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT02606305
What this trial is testing

Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
ImmunoGen, Inc. 264
Early research (Phase 1)Looking for participantsNCT07658196
What this trial is testing

TLR9 Immunotherapy for Peritoneal Carcinomatosis

Who this might be right for
Malignant AscitesColorectal AdenocarcinomaPeritoneal (Metastatic) Cancer+1 more
Brown University 24
Testing effectiveness (Phase 2)Study completedNCT04387227
What this trial is testing

Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
University of Washington 22
Testing effectiveness (Phase 2)Study completedNCT01720173
What this trial is testing

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Gynecologic Oncology Group 30
Testing effectiveness (Phase 2)Study completedNCT00859469
What this trial is testing

Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

Who this might be right for
Mesothelioma
Columbia University 29
Not applicableUnknownNCT06344923
What this trial is testing

Peritoneum and Anterior Rectus Sheath Suturing and Ileostomy

Who this might be right for
Ileostomy - StomaRectal Neoplasms
Qilu Hospital of Shandong University 120
Not applicableActive Not RecruitingNCT05038254
What this trial is testing

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Who this might be right for
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+42 more
M.D. Anderson Cancer Center 750
Early research (Phase 1)Study completedNCT00402766
What this trial is testing

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma

Who this might be right for
Mesothelioma
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00671788
What this trial is testing

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Gynecologic Oncology Group 35
Not applicableUnknownNCT04001023
What this trial is testing

Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma+1 more
Turku University Hospital 40
Large-scale testing (Phase 3)Ended earlyNCT01281254
What this trial is testing

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
Amgen 223
Not applicableLooking for participantsNCT05755672
What this trial is testing

On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

Who this might be right for
Metastatic Colorectal CancerChemotherapy EffectPeritoneal Metastases+2 more
Region Skane 100
Testing effectiveness (Phase 2)Study completedNCT00063401
What this trial is testing

Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPeritoneal NeoplasmsFallopian Tube Neoplasms
Eli Lilly and Company 39
Testing effectiveness (Phase 2)Study completedNCT03126812
What this trial is testing

Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer Stage IVPeritoneal CancerFallopian Tube Cancer
The Netherlands Cancer Institute 33
Not applicableStudy completedNCT06870539
What this trial is testing

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

Who this might be right for
Cancer-related Cognitive DysfunctionCytomegaloviral InfectionFallopian Tube Carcinoma+2 more
Mayo Clinic 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04739800
What this trial is testing

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Who this might be right for
Fallopian Tube Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaPlatinum-Refractory Fallopian Tube Carcinoma+47 more
National Cancer Institute (NCI) 120
Next Page